Cargando…

Blood‐based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)

Circulating protein markers were assessed in patients with colorectal cancer (CRC) treated with cetuximab in CALGB 80203 to identify prognostic and predictive biomarkers. Patients with locally advanced or metastatic CRC received FOLFOX or FOLFIRI chemotherapy (chemo) or chemo in combination with cet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hatch, Ace J., Sibley, Alexander B., Starr, Mark D., Brady, J. Chris, Jiang, Chen, Jia, Jingquan, Bowers, Daniel L., Pang, Herbert, Owzar, Kouros, Niedzwiecki, Donna, Innocenti, Federico, Venook, Alan P., Hurwitz, Herbert I., Nixon, Andrew B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055181/ https://www.ncbi.nlm.nih.gov/pubmed/27465221 http://dx.doi.org/10.1002/cam4.806

Ejemplares similares

Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance)
por: Fuchs, Michael A., et al.
Publicado: (2014)

Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)
por: Brown, Justin C, et al.
Publicado: (2019)

Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance)
por: Lee, Seohyuk, et al.
Publicado: (2021)

Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405
por: Guercio, Brendan J, et al.
Publicado: (2020)

IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405
por: Guercio, Brendan J, et al.
Publicado: (2020)

Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance)
por: Fadelu, Temidayo, et al.
Publicado: (2018)

Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 (Alliance)
por: Brown, Justin C, et al.
Publicado: (2018)

Genetic variation determines VEGF-A plasma levels in cancer patients
por: Innocenti, Federico, et al.
Publicado: (2018)

Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance)
por: Guercio, Brendan J., et al.
Publicado: (2018)

Polygenic Inheritance of Paclitaxel-Induced Sensory Peripheral Neuropathy Driven by Axon Outgrowth Gene Sets in CALGB 40101 (Alliance)
por: Chhibber, Aparna, et al.
Publicado: (2014)

Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance)
por: Lee, Seohyuk, et al.
Publicado: (2022)

fastJT: An R package for robust and efficient feature selection for machine learning and genome-wide association studies
por: Lin, Jiaxing, et al.
Publicado: (2019)

A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance)
por: Kim, Hyung L., et al.
Publicado: (2015)

Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104)
por: Gajewski, Thomas F, et al.
Publicado: (2012)

Long‐term trajectories of self‐reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance)
por: Mandelblatt, Jeanne S., et al.
Publicado: (2016)

Updated analysis of CALGB 100104 (Alliance): a randomised phase III study evaluating lenalidomide vs placebo maintenance after single autologous stem cell transplant for multiple myeloma
por: Holstein, Sarah A., et al.
Publicado: (2017)

Characteristics of toxicity occurrence patterns in concurrent chemoradiotherapy after induction chemotherapy for patients with locally advanced non-small cell lung cancer: a pooled analysis based on individual patient data of CALGB/Alliance trials
por: Yang, Lexie Zidanyue, et al.
Publicado: (2022)

Randomisierte Phase-II-Studie zur an der PET-Response orientierten multimodalen Therapie des Speiseröhrenkrebses – Ergebnisse des CALGB 80803 (Alliance) Trial
por: Bauer, Lukas, et al.
Publicado: (2022)

CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer
por: Shepherd, Jonathan H., et al.
Publicado: (2022)

Next Generation Distributed Computing for Cancer Research
por: Agarwal, Pankaj, et al.
Publicado: (2015)

Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer
por: Liu, Yingmiao, et al.
Publicado: (2014)

The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation
por: Innocenti, Federico, et al.
Publicado: (2018)

MRE11-Deficiency Associated with Improved Long-Term Disease Free Survival and Overall Survival in a Subset of Stage III Colon Cancer Patients in Randomized CALGB 89803 Trial
por: Pavelitz, Thomas, et al.
Publicado: (2014)

Age and the Risk of Paclitaxel‐Induced Neuropathy in Women with Early‐Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101
por: Barginear, Myra, et al.
Publicado: (2018)

Outcomes of a Modified CALGB 19802 Regimen in Adult Acute Lymphoblastic Leukemia
por: Han, A-Reum, et al.
Publicado: (2008)

A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer
por: Strickler, John H., et al.
Publicado: (2019)

Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab
por: Liu, Yingmiao, et al.
Publicado: (2013)

Mapping eQTL by leveraging multiple tissues and DNA methylation
por: Acharya, Chaitanya R., et al.
Publicado: (2017)

Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan
por: Ma’koseh, Mohammad, et al.
Publicado: (2021)

A modified CALGB 10403 in adolescents and young adults with acute lymphoblastic leukemia in Central America
por: Rangel-Patiño, Juan, et al.
Publicado: (2023)

Efficient estimation of grouped survival models
por: Li, Zhiguo, et al.
Publicado: (2019)

permGPU: Using graphics processing units in RNA microarray association studies
por: Shterev, Ivo D, et al.
Publicado: (2010)

Exploiting expression patterns across multiple tissues to map expression quantitative trait loci
por: Acharya, Chaitanya R., et al.
Publicado: (2016)

ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer
por: Johnson, Radia M., et al.
Publicado: (2022)

Geriatric assessment for older adults receiving less-intensive therapy for acute myeloid leukemia: report of CALGB 361101
por: Ritchie, Ellen K., et al.
Publicado: (2022)

DNA-Damage-Induced Alternative Splicing of p53
por: Chen, Jing, et al.
Publicado: (2021)

SNPpy - Database Management for SNP Data from Genome Wide Association Studies
por: Mitha, Faheem, et al.
Publicado: (2011)

A permutation-based multiple testing method for time-course microarray experiments
por: Sohn, Insuk, et al.
Publicado: (2009)

Robust test method for time-course microarray experiments
por: Sohn, Insuk, et al.
Publicado: (2010)

Measuring Disease-Free Survival and Cancer Relapse Using Medicare Claims From CALGB Breast Cancer Trial Participants (Companion to 9344)
por: Lamont, Elizabeth B., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_fv6c0t0uqo64rabka7b8elu77j